Method of performing a lab developed test

Patent metadata

Field	Value
Publication number	US-2025163503-A1
Application number	US-202519021925-A
Country	US
Kind code	A1
Filing date	Jan 15, 2025
Priority date	Jul 10, 2017
Publication date	May 22, 2025
Grant date	—

Abstract

Performing multiple nucleic acid amplification assays in an automated analyzer comprises loading the analyzer with a sample-containing receptacles, producing a purified form of a first sample to isolate a first analyte, producing a purified form of a second sample to isolate a second analyte, forming first and second amplification reaction mixtures with the purified first and second samples, the first mixture containing first amplification oligomers for amplifying a first region of the first analyte and the second mixture containing second amplification oligomers for amplifying a second region of the second analyte, exposing the second mixture to thermal conditions for amplifying the second region, exposing the first mixture to thermal conditions for amplifying the first region, determining the presence or absence of the second analyte in the second mixture, and determining the presence or absence of the first analyte in the first mixture.

First claim

1 . A method of performing a plurality of nucleic acid amplification assays in an automated analyzer, the method comprising the steps of:
(a) loading the analyzer with a plurality of sample-containing receptacles; (b) producing a purified form of a first sample contained in one of the plurality of sample-containing receptacles by exposing the first sample to reagents and conditions adapted to isolate and purify a first analyte which may be present in the first sample; (c) after initiating step (b), producing a purified form of a second sample contained in one of the plurality of sample-containing receptacles by exposing the second sample to reagents and conditions adapted to isolate and purify a second analyte which may be present in the second sample; (d) forming a first amplification reaction mixture with the purified form of the first sample and a second amplification reaction mixture with the purified form of the second sample, wherein the first amplification reaction mixture contains a first set of amplification oligomers for amplifying a first region of the first analyte or a nucleic acid bound to the first analyte in a first nucleic acid amplification reaction, and wherein the second amplification reaction mixture contains a second set of amplification oligomers for amplifying a second region of the second analyte or a nucleic acid bound to the second analyte in a second nucleic acid amplification reaction; (e) exposing the second amplification reaction mixture to thermal conditions for amplifying the second region in the second nucleic acid amplification reaction; (f) after initiating step (e), exposing the first amplification reaction mixture to thermal conditions for amplifying the first region in the first nucleic acid amplification reaction; (g) determining the presence or absence of the second analyte in the second amplification reaction mixture; and (h) after step (g), determining the presence or absence of the first analyte in the first amplification reaction mixture.

2 . The method of claim 1 , wherein the second sample is loaded onto the analyzer during or after step (b).

3 . The method of claim 1 , wherein the first and second samples are contained in a single sample-containing receptacle.

4 . The method of claim 1 , wherein steps (b) and (c) each comprise:
immobilizing the first or second analyte on a magnetically-responsive solid support, if the first and second analytes are present in the first and second samples, respectively; removing non-immobilized components of either the first or second sample while exposing the first or second sample to a magnetic field; and re-suspending the solid support in a buffered solution after removing the non-immobilized components of either the first or second sample.

5 . The method of claim 1 , further comprising the steps of:
(a) prior to forming the first amplification reaction mixture, dissolving a first amplification reagent containing a polymerase and the first set of amplification oligomers, wherein the first amplification reagent is dissolved with a first solvent, and wherein the first solvent does not contain an amplification oligomer or a polymerase; and (b) prior to forming the second amplification reaction mixture, dissolving a second amplification reagent containing a polymerase, wherein the second amplification reagent is dissolved with a second solvent containing the second set of amplification oligomers, and wherein the second amplification reagent does not contain an amplification oligomer.

6 . The method of claim 5 , wherein the first amplification reagent contains all oligomers necessary for performing the first nucleic acid amplification reaction, and wherein the second solvent contains all oligomers necessary for performing the second nucleic acid amplification reaction.

7 . The method of claim 6 , wherein the first amplification reagent and the second solvent each contain a detection probe.

8 . The method of claim 5 , wherein the second solvent is contained in a first vial supported by a first holder, and wherein the first holder supports one or more vials in addition to the first vial, and wherein at least one of the one or more vials contains a solvent that contains a set of amplification oligomers not contained in the second solvent.

9 . The method of claim 5 , wherein the first solvent is contained in a second holder having a sealed fluid reservoir and an access chamber that are fluidly connected, the access chamber being accessible by a fluid transfer device for removing the first solvent from the second holder.

10 . The method of claim 5 , wherein the first and second amplification reagents are stored and dissolved in mixing wells of the same or different reagent packs, each reagent pack including multiple mixing wells.

11 . The method of claim 5 , wherein the first set of amplification oligomers are used to perform an IVD assay, and wherein the second set of amplification oligomers are used to perform an LDT.

12 . The method of claim 1 , further comprising the steps of:
(a) prior to forming the first amplification reaction mixture, dissolving a first amplification reagent containing a polymerase, wherein the first amplification reagent is dissolved with a first solvent containing the first set of amplification oligomers, and wherein the first amplification reagent does not contain an amplification oligomer; and (b) prior to forming the second amplification reaction mixture, dissolving a second amplification reagent containing a polymerase and the second set of amplification oligomers, wherein the second amplification reagent is dissolved with a second solvent, and wherein the second solvent does not contain an amplification oligomer or a polymerase.

13 . The method of claim 12 , wherein the first solvent contains all oligomers necessary for performing the first nucleic acid amplification reaction, and wherein the second amplification reagent contains all oligomers necessary for performing the second nucleic acid amplification reaction.

14 . The method of claim 1 , wherein the first and second amplification reaction mixtures are formed in first and second reaction receptacles, respectively.

15 . The method of claim 14 , wherein an oil is dispensed into each of the first and second reaction receptacles prior to steps (f) and (e), respectively.

16 . The method of claim 14 , further comprising:
closing each of the first and second reaction receptacles with a cap prior to steps (f) and (e), respectively; and centrifuging the closed first and second reaction receptacles prior to steps (f) and (e), respectively.

17 . The method of claim 1 , further comprising:
contacting the purified forms of the first and second samples with an elution buffer prior to step (d), such that the purified forms of the first and second samples are contained in first and second eluates, respectively, when forming the first and second amplification reaction mixtures; transferring an aliquot of at least one of the first and second eluates to a storage receptacle prior to forming the first or second amplification reaction mixture; closing the storage receptacle with a cap; retaining the storage receptacle within the analyzer at least until the completion of step (g); forming a third amplification reaction mixture with the aliquot in the storage receptacle after at least one of steps (g) and (h), wherein the third amplification reaction mixture contains a third set of amplification oligomers for amplifying a third region of a third analyte or a nucleic acid bound to the third analyte in a th

Assignees

• Gen Probe Inc

Inventors

• Tidd Jennifer L
• Shapiro Anne-Laure
• Shah Ankur H
• Tuggle James T
• Opalsky David
• Lio Alberto A
• Scheer Timothy J
• Rhubottom Jason F
• Buse David Aaron

Classifications

• C12Q2565/629

  being a microfluidic device · CPC title

• C12Q2531/113

  PCR · CPC title

• C12Q2527/101

  Temperature · CPC title

• C12Q2523/32

  Centrifugation · CPC title

• G01N35/0098

  involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation (magnetic particles used in immunoassays G01N33/54326; magnetic separation in general B03C) · CPC title